Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

K. B. Bukan; A. Nardo-Marino; C. Hagdrup; M. Boennelycke; M. F. Breinholdt; C. Schöllkopf; H. V. Nielsen; D. El Fassi

doi:10.1080/03009742.2018.1533035

Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

K. B. Bukan^*, A. Nardo-Marino, C. Hagdrup, M. Boennelycke, M. F. Breinholdt, C. Schöllkopf, H. V. Nielsen, D. El Fassi

^*Corresponding author for this work

Department of Clinical Medicine

Original language	English
Journal	Scandinavian Journal of Rheumatology
Volume	48
Issue number	4
Pages (from-to)	342-343
ISSN	0300-9742
DOIs	https://doi.org/10.1080/03009742.2018.1533035
Publication status	Published - 4 Jul 2019

Access to Document

10.1080/03009742.2018.1533035

Cite this

Bukan, K. B., Nardo-Marino, A., Hagdrup, C., Boennelycke, M., Breinholdt, M. F., Schöllkopf, C., Nielsen, H. V., & El Fassi, D. (2019). Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy. Scandinavian Journal of Rheumatology, 48(4), 342-343. https://doi.org/10.1080/03009742.2018.1533035

Bukan, KB, Nardo-Marino, A, Hagdrup, C, Boennelycke, M, Breinholdt, MF, Schöllkopf, C, Nielsen, HV & El Fassi, D 2019, 'Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy', Scandinavian Journal of Rheumatology, vol. 48, no. 4, pp. 342-343. https://doi.org/10.1080/03009742.2018.1533035

@article{50d1c7559bc14581975fe1591fe0d67c,

title = "Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy",

author = "Bukan, {K. B.} and A. Nardo-Marino and C. Hagdrup and M. Boennelycke and Breinholdt, {M. F.} and C. Sch{\"o}llkopf and Nielsen, {H. V.} and {El Fassi}, D.",

year = "2019",

month = jul,

day = "4",

doi = "10.1080/03009742.2018.1533035",

language = "English",

volume = "48",

pages = "342--343",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation

T2 - a potential adverse event to anti-tumour necrosis factor-α therapy

AU - Bukan, K. B.

AU - Nardo-Marino, A.

AU - Hagdrup, C.

AU - Boennelycke, M.

AU - Breinholdt, M. F.

AU - Schöllkopf, C.

AU - Nielsen, H. V.

AU - El Fassi, D.

PY - 2019/7/4

Y1 - 2019/7/4

UR - http://www.scopus.com/inward/record.url?scp=85058400197&partnerID=8YFLogxK

U2 - 10.1080/03009742.2018.1533035

DO - 10.1080/03009742.2018.1533035

M3 - Letter

C2 - 30526204

AN - SCOPUS:85058400197

SN - 0300-9742

VL - 48

SP - 342

EP - 343

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 4

ER -

Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

Access to Document

Other files and links

Cite this